The 5th Commercializing Continuous Processing in Pharma 2021 reunited the growing CCP community to discuss how to accelerate adoption of continuous processing in a GMP environment.

We have reached the inflection point that continuous manufacturing is a must-have capability for drug developers and CMOs – as it offers tremendous opportunities to fast track treatments to patients through flexible manufacturing for rapid response and emerging therapeutics.

More important than ever, the industry and patients need a flexible and agile option to scale-up, guaranteeing capacity for speed-to-market. As the only meeting dedicated to commercial continuous manufacturing, this is the definitive summit to meet, share and be inspired by both small molecules and biologics pioneers.

Click here to register your interest for next year’s event.